1. Home
  2. ARQT vs BFC Comparison

ARQT vs BFC Comparison

Compare ARQT & BFC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARQT
  • BFC
  • Stock Information
  • Founded
  • ARQT 2016
  • BFC 1894
  • Country
  • ARQT United States
  • BFC United States
  • Employees
  • ARQT N/A
  • BFC N/A
  • Industry
  • ARQT Biotechnology: Pharmaceutical Preparations
  • BFC Major Banks
  • Sector
  • ARQT Health Care
  • BFC Finance
  • Exchange
  • ARQT Nasdaq
  • BFC Nasdaq
  • Market Cap
  • ARQT 1.1B
  • BFC 903.7M
  • IPO Year
  • ARQT 2020
  • BFC N/A
  • Fundamental
  • Price
  • ARQT $10.14
  • BFC $106.79
  • Analyst Decision
  • ARQT Strong Buy
  • BFC Hold
  • Analyst Count
  • ARQT 4
  • BFC 1
  • Target Price
  • ARQT $15.50
  • BFC $104.00
  • AVG Volume (30 Days)
  • ARQT 2.2M
  • BFC 18.7K
  • Earning Date
  • ARQT 11-06-2024
  • BFC 01-14-2025
  • Dividend Yield
  • ARQT N/A
  • BFC 1.69%
  • EPS Growth
  • ARQT N/A
  • BFC 53.70
  • EPS
  • ARQT N/A
  • BFC 8.15
  • Revenue
  • ARQT $138,708,000.00
  • BFC $184,220,000.00
  • Revenue This Year
  • ARQT $208.32
  • BFC N/A
  • Revenue Next Year
  • ARQT $48.56
  • BFC $8.37
  • P/E Ratio
  • ARQT N/A
  • BFC $13.11
  • Revenue Growth
  • ARQT 182.84
  • BFC 26.32
  • 52 Week Low
  • ARQT $1.76
  • BFC $74.90
  • 52 Week High
  • ARQT $13.17
  • BFC $109.83
  • Technical
  • Relative Strength Index (RSI)
  • ARQT 55.70
  • BFC 64.71
  • Support Level
  • ARQT $8.90
  • BFC $100.44
  • Resistance Level
  • ARQT $10.72
  • BFC $103.15
  • Average True Range (ATR)
  • ARQT 0.70
  • BFC 3.60
  • MACD
  • ARQT 0.05
  • BFC 0.08
  • Stochastic Oscillator
  • ARQT 56.52
  • BFC 82.81

About ARQT Arcutis Biotherapeutics Inc.

Arcutis Biotherapeutics Inc is a medical dermatology company. It is developing treatments for patients with immune-mediated dermatological diseases and conditions. It is leveraging recent advances in immunology and inflammation to develop differentiated therapies against biologically validated targets to solve persistent treatment challenges in serious diseases of the skin. The company's lead product candidate ZORYVE roflumilast cream, has successfully completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population.

About BFC Bank First Corporation

Bank First Corp is a United States-based company engaged in providing financial services provides a full range of consumer and commercial financial institution services to individuals and businesses including retail and commercial banking in Wisconsin. These services include credit cards; secured and unsecured consumer, commercial, and real estate loans; demand, time, and savings deposits; and ATM processing. The Corporation also offers a full line of insurance services and checking accounts, savings accounts, money market accounts, cash management accounts, certificates of deposit, commercial and industrial loans, commercial real estate loans, construction and development loans, residential mortgages, consumer loans, credit cards, online banking, telephone banking, and mobile banking.

Share on Social Networks: